(FMC) FMC - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US3024913036
FMC: Insecticides, Herbicides, Fungicides, Biologicals, Crop Nutrition
FMC Corporation (NYSE:FMC) is a leading global agricultural sciences company specializing in innovative crop protection solutions. With operations spanning Latin America, North America, Europe, the Middle East, Africa, and Asia, FMC develops, manufactures, and markets a comprehensive portfolio of insecticides, herbicides, fungicides, biologicals, crop nutrition products, and seed treatments. These solutions are designed to enhance crop yield and quality by effectively managing insects, weeds, and diseases in agricultural settings. Additionally, FMC serves non-agricultural markets, including pest control. The company distributes its products through a combination of its direct sales force, alliance partners, independent distributors, and sales representatives. Founded in 1883, FMC Corporation is headquartered in Philadelphia, Pennsylvania, and has established itself as a pioneer in agricultural chemistry with a strong commitment to research and development. The companys focus on sustainability and precision agriculture positions it as a key player in the global food security effort.
Over the next three months, FMC Corporations stock is expected to show moderate growth, supported by strong fundamental momentum. The current price of $41.18, coupled with SMA 20 and SMA 50 levels of 38.57 and 38.96 respectively, indicates a short-term uptrend. The stock is trading below its SMA 200 of 52.11, suggesting potential long-term consolidation. With an ATR of 1.67, volatility is expected to remain moderate. Fundamentally, FMCs market cap of $4.633 billion, P/E ratio of 11.56, and forward P/E of 10.92 signal undervaluation relative to its earnings growth potential. The P/B ratio of 1.03 reflects a reasonable valuation of its assets. With a P/S ratio of 1.09 and an RoE of 7.60, the company demonstrates stable profitability and efficient asset utilization. These metrics, combined with FMCs strong R&D pipeline and expanding market presence, point to a positive outlook for the stock in the near term.
Additional Sources for FMC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FMC Stock Overview
Market Cap in USD | 4,485m |
Sector | Basic Materials |
Industry | Agricultural Inputs |
GiC Sub-Industry | Fertilizers & Agricultural Chemicals |
IPO / Inception | 1985-07-01 |
FMC Stock Ratings
Growth Rating | -65.5 |
Fundamental | -3.04 |
Dividend Rating | 67.3 |
Rel. Strength | -37.7 |
Analysts | 3.55/5 |
Fair Price Momentum | 31.97 USD |
Fair Price DCF | 41.79 USD |
FMC Dividends
Dividend Yield 12m | 5.07% |
Yield on Cost 5y | 2.90% |
Annual Growth 5y | 5.21% |
Payout Consistency | 99.0% |
FMC Growth Ratios
Growth Correlation 3m | 17.7% |
Growth Correlation 12m | -69.8% |
Growth Correlation 5y | -57.2% |
CAGR 5y | -14.49% |
CAGR/Max DD 5y | -0.20 |
Sharpe Ratio 12m | -0.53 |
Alpha | -50.38 |
Beta | 0.809 |
Volatility | 57.90% |
Current Volume | 2477k |
Average Volume 20d | 1804.8k |
As of May 09, 2025, the stock is trading at USD 36.60 with a total of 2,477,011 shares traded.
Over the past week, the price has changed by -4.81%, over one month by +7.71%, over three months by +5.73% and over the past year by -40.96%.
Neither. Based on ValueRay Fundamental Analyses, FMC is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -3.04 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FMC as of May 2025 is 31.97. This means that FMC is currently overvalued and has a potential downside of -12.65%.
FMC has received a consensus analysts rating of 3.55. Therefor, it is recommend to hold FMC.
- Strong Buy: 5
- Buy: 2
- Hold: 12
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, FMC FMC will be worth about 34.5 in May 2026. The stock is currently trading at 36.60. This means that the stock has a potential downside of -5.66%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 47.7 | 30.3% |
Analysts Target Price | 47.6 | 30.2% |
ValueRay Target Price | 34.5 | -5.7% |